IL-33 is related to pathogenic mechanisms in neurodegenerative disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), multiple sclerosis (MS), Huntington’s disease (HD), chronic traumatic encephalopathy (CTE), and amyotrophic lateral sclerosis (ALS). The gene discussed is IL33; the disease is Huntington disease.